Nitrosamines in Pharmaceutical Products

By Anonymous (not verified), 8 August, 2025
Short Description

A class of potent, potentially carcinogenic impurities that can form in certain products, requiring rigorous risk assessments and testing to ensure their absence at unacceptable levels.